Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes†
Nadia Aïssaoui(Université Paris Cité), Jean-Yves Fagon(Royal Statistical Society), Étienne Puymirat(Inserm), Guillaume Lebreton(Inserm), Shaïda Varnous(Université Paris-Est Créteil), Jan Gummert(Heart and Diabetes Center North Rhine-Westphalia), Lech Paluszkiewicz(Heart and Diabetes Center North Rhine-Westphalia), Christian Latrémouille(Université Paris Cité), Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Matthias Brunn(Inserm), S. Ouldamar(Université Paris-Est Créteil), Michiel Morshuis(Heart and Diabetes Center North Rhine-Westphalia), R. Guillemain(Université Paris Cité), Uwe Schulz(Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR)), Benoı̂t Diébold(Hôpital Cochin), Kavous Hakim‐Meibodi(Heart and Diabetes Center North Rhine-Westphalia), Pascal Leprince(Sorbonne Université), Michael Schoenbrodt(Heart and Diabetes Center North Rhine-Westphalia), Isabelle Durand‐Zaleski(Inserm), Gilles Châtellier(Hôpital Saint Joseph), Pierre Mutuon, Hassani Maoulida, Joe‐Elie Salem(Inserm), Marc Barreira(Inserm), Emmanuel Guérot(Délégation Paris 5), Albert Hagège, Paul Guedeney(Université Paris Cité)
Cited by 21
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase
|Circulation|2003|928
Spatial multi-omic map of human myocardial infarction
|Nature|2022|692
Acute Myocardial Infarction
|Circulation|2017|534